SLAMF1 antibody (AA 296-325)
Quick Overview for SLAMF1 antibody (AA 296-325) (ABIN358048)
Target
See all SLAMF1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 296-325
-
Specificity
- This antibody detects CD150/SLAMF1.
-
Purification
- Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
-
Immunogen
- This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 296~325 amino acids surrounding Y307 of Human SLAMF1.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
-
ELISA: 1/1,000. Western Blot: 1/50-1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium Azide as preservative.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
-
-
- SLAMF1 (Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1))
-
Alternative Name
- CD150 / SLAMF1
-
Background
- SLAMF1 is high-affinity self-ligand important in bidirectional T-cell to B-cell stimulation. SLAM-induced signal-transduction events in T-lymphocytes are different from those in B-cells. Two modes of SLAM signaling are likely to exist: one in which the inhibitor SH2D1A acts as a negative regulator and another in which protein-tyrosine phosphatase 2C (PTPN11)-dependent signal transduction operates.Synonyms: CDw150, Ipo-3, Signaling lymphocytic activation molecule, Slam
-
Molecular Weight
- 37231 Da
-
Gene ID
- 6504, 9606
-
UniProt
- Q13291
Target
-